News Releases
June 2, 2005
Closure Medical
Stockholders Approve Acquisition Agreement With Johnson &
Johnson
March 4, 2005
Johnson & Johnson
and CLOSURE Medical Corporation Announce Acquisition Agreement
Acquisition to Strengthen Presence in Topical Adhesives and
Surgical Sealants
February 23, 2005
Closure Medical
Reports Fourth Quarter and Fiscal Year 2004 Results
February 22, 2005
Closure Medical
Receives European Approval For OMNEX™ Surgical Sealant,
Its First Internal Product
February 18, 2005
Closure Medical
Announces Date of Its Fourth Quarter and Year-End 2004 Results
Release and Conference Call
February 03, 2005
Closure Medical
Corporation To Present At The Merrill Lynch 2005 Global Pharmaceutical,
Biotechnology & Medical Device Conference
January 11, 2005
Closure Medical
Provides 2005 Financial Guidance
January 6, 2005
Closure Medical
Corporation To Present At The Seventh Annual Needham Growth
Conference
December 16, 2004
Closure Medical
Announces Date Of Its 2005 Financial Guidance Release And
Conference Call
October 13, 2004
Closure Medical
Reports Third Quarter 2004 Results
October 6, 2004
Closure Medical
Announces Date of Its Third Quarter 2004 Results Release and
Conference Call
September 29, 2004
Closure Medical
Revises 2004 Financial Outlook
July 22, 2004
Closure Medical
Reports 33 Percent Increase In Revenues And 52 Percent Increase
In Net Income For Second Quarter 2004
July 15, 2004
Closure Medical
Announces Date Of Its Second Quarter 2004 Results Release
And Conference Call
June 16, 2004
Closure Medical
Elects J. Daniel Cole Chairman Of The Board Of Directors
June 1, 2004
Closure Medical
Corporation To Present At The Pacific Growth Equities Life
Sciences Growth Conference
April 15, 2004
Closure Medical
Reports First Quarter Revenues of $10.5 Million, Up 28 Percent
From Prior Year Period
April 13, 2004
Closure Medical
Receives Medical Design Excellence Award
March 18, 2004
Closure Medical
announces FDA approval to begin pivotal clinical study for
its vascular sealant product
February 12, 2004
Closure Medical
reports fourth quarter 2003 results
January 6, 2004
Closure Medical
appoints three new Vice Presidents
November 20, 2003
Closure Medical
provides 2004 financial guidance
November 4, 2003
Closure Medical
Corporation initiates patient enrollment in pilot study for
its vascular sealant product
October 20, 2003
Closure Medical
Introduces new Dermabond delivery devices
October 16, 2003
Closure Medical
reports third quarter 2003 results
October 2, 2003
Stephen I. Shapiro
joins board of Closure Medical Corporation
September 17, 2003
Closure Medical
to present at the UBS Warburg Global Life Sciences conference
July 17, 2003
Closure Medical
reports record second quarter results
July 1, 2003
J. Daniel Cole joins
board of Closure Medical Corporation
April 16, 2003
Closure Medical
reports first quarter results
March 17, 2003
Closure Medical
names James F. Buck Vice President of Marketing
February 14, 2003
Closure Medical
reports record earnings and double-digit revenue growth for
its fourth quarter and full year 2002
January 29, 2003
Closure Medical
Corp to present at Merrill Lynch Global Pharmaceutical, Biotech
& Medical Device conference in New York City
January 22, 2003
Band Aid Brand®
Liquid Bandage receives Good Housekeeping's "Good Buy"
award
January 2, 2003
Closure Medical
receives FDA approval to market its new high viscosity Dermabond
topical skin adhesive
October 17, 2002
Closure Medical
reports third quarter, nine month results
September 4, 2002
Daniel A. Pelak
appointed as President and Chief Executive Officer of Closure
Medical
July 23, 2002
Closure Medical
reports second quarter 2002 results
April 23, 2002
Closure Medical
reports first quarter 2002 results
February 19, 2002
Closure Medical
reports fourth quarter and year-end 2001 results
January 24, 2002
Closure Medical
Corporation to participate in the U.S. Bancorp Piper Jaffray
Health Care conference
January 16 , 2002
Dermabond adhesive
receives FDA approval for enhanced device labeling
November 26 , 2001
Closure Medical
Corporation to participate in the Robertson Stephens medical
conference
November 7 , 2001
Closure Medical
provides Johnson & Johnson Wound Management exclusive
rights to occlusive dressing technology, the company's fifth
major product platform
October 23 , 2001
Closure Medical
Corporation reports record revenue and earnings for the third
quarter and first nine months of 2001; expects 30-35% revenue
growth for 2002
October 16 , 2001
James E. Niedel,
former Chief Science and Technology Officer of GlaxoSmithKline
PLC, joins board of Closure Medical Corporation
October 16 , 2001
Closure Medical
to webcast conference call discussing third quarter 2001 results
and outlook for 2002
July 30, 2001
Closure Medical
adopts stockholder rights plan
July 24, 2001
Closure Medical
Corporation reports record revenues for the second quarter
and first half of 2001
July 17, 2001
Closure Medical
announces agreement with Abbott Laboratories for Nexaband®
product line for veterinary wound care
May 29, 2001
Closure Medical
signs definitive agreement with Johnson & Johnson Consumer
Companies, Inc. for its Liquiderm™ liquid adhesive bandage
April 24, 2001
Closure Medical
reports first quarter results
April 17, 2001
Closure Medical
to webcast first quarter 2001 conference call
February 20, 2001
Closure Medical
reports fourth quarter results
February 6, 2001
Closure enters research
agreement to develop medical adhesive for the treatment of
emphysema
January 31, 2001
Closure Medical
Corporation announces FDA approval of Liquiderm™ Liquid
Adhesive Bandage
January 11, 2001
Closure Medical
provides guidance for Q4 2000 and for fiscal year 2001
December 21, 2000
Closure Medical
announces Soothe-n-Seal™ agreement with Colgate
October 26, 2000
Closure Medical
reports third quarter results
October 23, 2000
Closure Medical
schedules date for third-quarter financial results and conference
call
August 1, 2000
Closure Medical
files 510(k) application for U.S. marketing clearance of its
Liquiderm™ Liquid Adhesive Bandage
July 25, 2000
Closure Medical
reports second quarter results
April 25, 2000
Closure Medical
reports first quarter results
March 28, 2000
Closure Medical
announces human clinical study for Liquiderm™ Liquid
Healing Bandage
February 16, 2000
Closure Medical Corporation receives
clearance for marketing Dermabond® in Japan
February 16, 2000
Closure Medical
Corporation reports fourth quarter results
December 8, 1999
Closure Medical
Corporation elects Ronald A. Ahrens as chairman of its board
of directors
October 21, 1999
Closure Medical
Corporation reports third quarter results
September 7, 1999
Closure Medical
announces FDA approval of Soothe-n-Seal™ canker sore
relief
August 4, 1999
Closure Medical
Corporation awarded U.S. patent relevant to Dermabond™
topical skin adhesive
July 15, 1999
Closure Medical
Corporation reports second quarter results
June 8, 1999
Closure Medical
Corporation announces filing of 510(k) for Soothe-n-Seal™
canker sore relief
April 22, 1999
Closure Medical
Corporation reports first quarter results
February 19, 1999
TV drama “ER”
showcases new Dermabond™ topical skin adhesive
February 10, 1999
Closure Medical
Corporation reports fourth quarter results
January 4, 1999
Ronald A. Ahrens
joins Closure Medical Corporation board of directors
November 23, 1998
One-year follow-up
highlights excellent cosmetic results with Dermabond™
topical skin adhesive
October 21, 1998
Closure Medical
Corporation third quarter results
August 27, 1998
Closure Medical
announces FDA approval of Dermabond™ topical skin adhesive
July 27, 1998
Closure Medical
Corporation announces second quarter results
June 3, 1998
Closure Medical
completes pilot clinical study for treatment of oral ulcers
April 20, 1998
Closure Medical
Corporation announces first quarter results
March 31, 1998
Debra L. Pawl joins
Closure Medical Corporation as Vice President and General
Counsel
March 11, 1998
Closure Medical
relocates to 50,000 square foot facility
February 2, 1998
Closure Medical Corporation
fourth quarter results
January 30, 1998
FDA advisory panel
recommends approval of Closure Medical Corporation's Dermabond™
topical skin cohesive
|
